If Patients Don't Use Available Health Service Pricing Information, Is Transparency Still Important?

Area of Science:

• Health economics
• Health services research
• Consumer health informatics

Background:

• The U.S. health system exhibits significant pricing complexities and a lack of transparency unrelated to healthcare quality.
• Existing online tools aimed at price transparency have failed to substantially impact healthcare market efficiency or patient purchasing decisions.

Purpose of the Study:

• To evaluate the effectiveness of online health care price transparency tools in the U.S. market.
• To assess the current impact and future potential of price transparency in healthcare consumerism.
• To examine the ethical implications of price transparency, particularly concerning patient out-of-pocket expenses.

Main Methods:

• Analysis of the current landscape of online health care price transparency initiatives.
• Review of literature on consumer behavior and market functioning in response to price information.
• Ethical considerations regarding patient access to and use of pricing data.

Main Results:

• Online price transparency tools have had minimal impact on healthcare market performance and patient behavior to date.
• Price transparency, while nascent, shows potential for empowering patient-consumers and informing policymakers, similar to its utility for large purchasers.
• Despite limited patient utilization, the ethical imperative for price transparency is growing due to increasing patient financial responsibility.

Conclusions:

• Current online price transparency tools are insufficient to drive significant market change or alter patient behavior.
• The potential benefits of price transparency for patients, purchasers, and policymakers warrant continued development and exploration.
• Ethical considerations underscore the importance of price transparency, especially as patients bear higher out-of-pocket healthcare costs.